Anne has built 23andMe into one of the world’s largest databases of genetic information, and her team has created a community around sharing that information, as well as recruiting participants to many genome-wide studies at once. Anne joined us last year for 3 CEOs, but this time she’s back to talk about how 23andMe and their most recent acquisition, CureTogether, can empower consumers by giving them access to their genetic information and crowd-sourced treatment reviews.
The tools, devices, sensors and other technologies that will be used to collect and monitor health data and customize it to the user. Going forward, how will genomics, robotics and behavior change fit into personalized health?
We talked with Anne Wojcicki, CEO at 23andme, about the biggest challenges, trends and developments in health care technology at the Health 2.0 San Francisco 2011 Fall Conference.
Anne Wojcicki, Co-Founder and CEO, 23andme
Anne built 23andMe into one of the world’s largest databases of genetic information, and her team has created a community around sharing that information, as well as recruiting participants to many genome-wide studies at once. We’ve featured 23andme several times at Health 2.0 but this is the first time Anne’s been on stage with us.
Anne is interviewed by Russ Mitchell, Kaiser Health News. These days Russ focuses on Health IT for Kaiser Health news, but he’s worked for virtually every business and IT focused publication out there, including Wired, Business 2.0 and US News & World report.
Here we hear 3 CEOs of companies transforming, and being transformed by, Health 2.0 in conversations about the future of their businesses. Anne Wojcicki is the Co-Founder and CEO, 23andme, is interviewed by Russ Mitchell of Kaiser Health News. West Shell, Chairman and CEO of Healthline, is interviewed by Zina Moukheiber of Forbes. Sona Mehring, Founder and CEO of CaringBridge, is interviewed by Chris Rauber of San Francisco Business Times.